For more than a year, Eli Lilly and Co. has been viewed by investors as a laggard stock with one, slim shot at producing a huge jackpot: its experimental Alzheimer’s drug. But now company leaders are trying to direct investor attention toward the drugmaker’s diabetes portfolio.
The Indiana Supreme Court this week will consider whether hospital billing practices should be put on trial. The state’s highest court will hear oral arguments Thursday in a case in which two uninsured patients have sued Indiana University Health for charging them much higher prices than it would have charged insured patients.
Health care firms have opened a flurry of clinics at Hoosier employers the past two years as businesses increasingly embrace the concept as a way to restrain employee health costs.
When the same MRI at one facility costs $600 and at another costs $2,200, Dr. Robert Gregori would call that a business opportunity.
BioCrossroads Inc. has raised an $8.25 million seed fund in its second attempt to help startup life sciences companies grow to the point where they can attract venture capital or a corporate funder.
Health insurance customers in Indiana will get an estimated $16.5 million in rebates this year, but the average amount received per person will be less than the national average and less than 3 percent of the total cost of coverage.
Superintendent Scott Robison informally recommended in March that the school system take a pass on the new funding because it still does not fully cover the costs required to expand its kindergarten program from half days to full days.
First-quarter profit and revenue plunged at Carmel-based ITT Educational Services Inc. as enrollment of new students declined for the seventh straight quarter.
Sales at Indianapolis-based Dow AgroSciences grew 14 percent in the first quarter, to $1.8 billion, helped by an early planting season in North America and a buoyant agricultural market.
Lilly’s quarterly sales and profit fell due to lost patent protection on Gemzar and Zyprexa. But sales of antidepressant Cymbalta, blood thinner Effient, animal health products and sales in China grew by 20 percent or more.
The Indianapolis-based health insurer posted first-quarter earnings of $857 million, down from $927 million in the same period a year ago.
Indiana University Health announced Tuesday that it will give $75 million in additional funding over the next five years to ramp up research at the Indiana University School of Medicine and launch more clinical trials around the state.
A group of 123 doctors, nurse practitioners and physician assistants have formed the Eskenazi Medical Group in order to focus on maximizing patient care and related bonus payments at Wishard Health Services.
More people have jobs and yet the use of health care remains stagnant—which should drive nice profits when WellPoint Inc. reports first-quarter earnings on Wednesday. The trends even have some wondering if consumer-driven health plans are finally starting to make a real difference in Americans’ health care spending habits.
Fountain Square Academy, a charter middle and high school with about 270 students, will remain open after Ball State University decided to grant it a charter to continue operating after this school year.
Some proponents of the Mind Trust plan to restructure Indianapolis Public Schools are looking to advance its key principles the old-fashioned way: by electing pro-reform members to the IPS board.
IBM’s supercomputer Watson is already a “Jeopardy!” champion. Now, three doctors in Indianapolis are trying to teach it how to treat cancer.
In an hour-long defense of Indianapolis Public Schools, Superintendent Eugene White outlined plans to streamline administrative staff, create more choices for parents, direct more resources to the district’s most challenged schools and give more autonomy to its highest performing schools.
The proposal garnered support from the owners of 62 percent of Eli Lilly’s outstanding shares. To pass, the proposal needed approval from the owners of 80 percent of Lilly’s shares.
